Antiviral agents: To treat or not to treat? An old dilemma revisited in light of new data from the 2009 influenza A(H1N1) pandemic

Journal of Clinical Virology

Volumn 49, Issue 2, 2010, Pages 145-146

  Hernández, Juan Martínez ^a,b   López Rodas, Victoria ^b   Costas, Eduardo ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antiviral resistance; Influenza pandemic; Mortality; Oseltamivir treatment; Population genetics

Indexed keywords

ANTIVIRUS AGENT; OSELTAMIVIR;

DISEASE SEVERITY; DRUG EFFICACY; FRANCE; GENOTYPE; GERMANY; HUMAN; INFLUENZA A (H1N1); LETTER; MORTALITY; PANDEMIC INFLUENZA; POINT MUTATION; POPULATION GENETICS; PRESCRIPTION; PRIORITY JOURNAL; SPAIN; UNITED KINGDOM; VIRUS MUTATION; VIRUS RESISTANCE;

ANTIVIRAL AGENTS; DRUG UTILIZATION; EUROPE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; OSELTAMIVIR; PANDEMICS;

EID: 77956651363     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.07.001     Document Type: Letter

References (7)

1. Luria S.E., Delbrück M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 1943, 28:491-511.
2. Hill A.W., Guralnick R.P., Wilson M.J.C., Habib F., Janies D. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza. Infect Gen Evol 2009, 9:169-178.
3. Kimura M., Maruyama T. The mutational load with epistatic gene interactions in fitness. Genetics 1996, 54:1337-1351.
4. Hurt A.C., Ernest J., Deng Y.M., Iannello P., Besselaar T.G., Birch C., et al. Emergence and spread of oseltamivir-resistant A (H1N1) influenza viruses in Oceania South East Asia and South Africa. Antiviral Res 2009, 83:90-93.
5. Crotty S., Andino R. Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin. Microb Infect 2002, 4:1301-1307.
6. Hauge S.H., Blix H.S., Borgen K., Hungnes O., Dudman S.G., Aavitsland P. Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant Influenza A(H1N1) viruses in 2007-2008. Virol J 2009, 6:54-62.
7. Soderstrom H., Jarhult J.D., Olsen B., Lindberg R.H., Tanaka H., Fick J. Detection of the antiviral drug oseltamivir in aquatic environments. PLoS One 2009, 4:6064-6069.